Publication | Closed Access

Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: An open-label, blinded end point, randomized prospective trial (VitD-CHF trial)

Blinded End PointHypertensionHeart FailureVitd-chf TrialCardiovascular DiseaseCardiac CareDiuretic ResistanceProspective TrialMedicineCardiologyDiastolic Function